Company: BOLT
Filing Date: 2025-04-16
Form Type: PRE 14A
Source: 0000950170-25-054405
Chunk: 20

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-04-16
Form: PRE 14A
Chunk 20
---
 margin, borrow against our stock held in a margin account, or pledge our stock as collateral for a loan.

Meetings of the Board of Directors

The Board met seven times during the year ended December 31, 2024. The audit committee of the Board met four times, the compensation committee of the Board met three times, the nominating and corporate governance committee of the Board met one time during 2024, and the research and development committee of the Board met three times during 2024. In June 2024, the Board dissolved the research and development committee in light of our strategic pipeline prioritization and restructuring plan. All members of the Board, except Mr. Lee, attended at least 75% of the aggregate number of meetings of our Board and of each committee on which they served, that were held during 2024 and during which they served on the Board or such committees. Mr. Lee attended all of the meetings of the compensation committee held during 2024 during which he served on the committee, but was unable due to conflicts to attend two of the five meetings of the Board during 2024 that were held prior to his resignation in September 2024.

Director Attendance at Annual Meeting

We invite each member of the Board to attend our annual meetings of stockholders. Five of our directors attended our 2024 annual meeting of stockholders, which was held virtually. We do not have a formal policy regarding attendance by members of the Board at our annual meetings.

Limitations of Liability and Indemnification Matters

Our amended and restated certificate of incorporation contains provisions that limit the liability of our current and former directors for monetary damages to the fullest extent permitted by Delaware law. Delaware law provides that directors of a corporation will not be personally liable for monetary damages for any breach of fiduciary duties as directors, except liability for:

any breach of the director’s duty of loyalty to the corporation or its stockholders;

any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;

<div align='center'>11</div>

unlawful payments of dividends or unlawful stock repurchases or redemptions; or

any transaction from which the director derived an improper personal benefit.

Such limitation of liability does not apply to liabilities arising under federal securities laws and does not affect the availability of equitable remedies such as injunctive relief or rescission.

Our amended and restated certificate of incorporation authorizes us to indemnify our directors, officers, employees, and other agents to the fullest extent